Cargando…
NR2F6 as a Prognostic Biomarker in HNSCC
Head and neck squamous cell carcinoma (HNSCC)is the 6th most common cancer in humans worldwide and is associated with a poor prognosis for patients. NR2F6 has been identified as an immune checkpoint molecule in tumor-infiltrating T lymphocytes and is associated with a poor prognostic outcome in vari...
Autores principales: | Klapper, Luise, Ribbat-Idel, Julika, Kuppler, Patrick, Paulsen, Finn-Ole, Bruchhage, Karl-Ludwig, Rades, Dirk, Offermann, Anne, Kirfel, Jutta, Wollenberg, Barbara, Idel, Christian, Perner, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432340/ https://www.ncbi.nlm.nih.gov/pubmed/32752295 http://dx.doi.org/10.3390/ijms21155527 |
Ejemplares similares
-
CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC
por: Paulsen, Finn-Ole, et al.
Publicado: (2020) -
TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC
por: Klapper, Luise, et al.
Publicado: (2022) -
EVI1 as a Marker for Lymph Node Metastasis in HNSCC
por: Idel, Christian, et al.
Publicado: (2020) -
Immunologic “Cold” Squamous Cell Carcinomas of the Head and Neck Are Associated With an Unfavorable Prognosis
por: Ribbat-Idel, Julika, et al.
Publicado: (2021) -
TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC
por: von Bernuth, Amelie, et al.
Publicado: (2023)